Authors:
TIBILEVY Y
DEPOUVOURVILLE G
ROZENHOLC Y
GOURSOT G
CLERGUE F
DELEMONTEY B
FEISS P
LAXENAIRE MC
MARTY J
BERESNIAK A
Citation: Y. Tibilevy et al., EVALUATION OF BENEFITS RELATED TO REDUCED LENGTH OF STAYS IN POSTANESTHESIA CARE UNITS, International journal of technology assessment in health care, 14(1), 1998, pp. 172-179
Authors:
AUQUIER P
FRENCH D
DELAROZIERE JC
BERESNIAK A
SIMEONI MC
CHARPIN D
SAMBUC R
Citation: P. Auquier et al., FRENCH-LANGUAGE VALIDATION OF THE CHILDHOOD ASTHMA QUESTIONNAIRE - FORM-C, Quality of life research, 6(7-8), 1997, pp. 15-15
Authors:
AUQUIER P
FRENCH D
DELAROZIERE JC
PASCAL L
BERESNIAK A
SIMEONI MC
DUBUS JC
BERNARD JL
SAMBUC R
Citation: P. Auquier et al., FRENCH VERSION OF THE CHILDHOOD ASTHMA QUESTIONNAIRE-B - TOWARDS A SHORT-FORM, Quality of life research, 6(7-8), 1997, pp. 16-16
Citation: A. Beresniak et F. Taboulet, THE EVALUATION OF MEDICATION-RELATED SIDE -EFFECTS BY MEDICO-ECONOMICMODELING TECHNIQUES, Therapie, 52(1), 1997, pp. 59-63
Authors:
LAMOULIATTE H
CARRERE MO
RUZNIEWSKI P
BERESNIAK A
SLAMA A
Citation: H. Lamouliatte et al., COST-EFFECTIVENESS MODELING OF VARIOUS HELICOBACTER-PYLORI ERADICATION STRATEGIES IN DUODENAL-ULCER PATIENTS, Gastroenterology, 112(4), 1997, pp. 193-193
Authors:
TIBILEVY Y
DEPOUVOURVILLE G
GOURSOT G
CLERGUE F
DELEMONTEY B
FEISS P
LAXENAIRE MC
MARTY J
BERESNIAK A
Citation: Y. Tibilevy et al., ASSESSMENT OF THE DIRECT THEORETICAL COST OF A STAY IN A RECOVERY ROOM, Annales francaises d'anesthesie et de reanimation, 15(7), 1996, pp. 1113-1120
Authors:
CARRERE MO
LAMOULIATTE H
RUSZNIEWSKI P
BERESNIAK A
SLAMA A
Citation: Mo. Carrere et al., COST-EFFECTIVENESS MODELING OF VARIOUS ST RATEGIES FOR THE ERADICATION OF HELICOBACTER-PYLORI IN DUODENAL-ULCER TREATMENT, Sciences sociales et sante, 14(4), 1996, pp. 37-64
Authors:
HITCHINGS C
HYLAND M
FREUND D
BERESNIAK A
DAVEY P
Citation: C. Hitchings et al., ANTIASTHMA DRUGS - QUALITY-OF-LIFE RATING-SCALES AND SENSITIVITY TO LONGITUDINAL CHANGE - DISCUSSION, PharmacoEconomics, 6(4), 1994, pp. 328-329